These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2318594)

  • 1. Chromatic, spatial, and temporal losses of sensitivity in multiple sclerosis.
    Dain SJ; Rammohan KW; Benes SC; King-Smith PE
    Invest Ophthalmol Vis Sci; 1990 Mar; 31(3):548-58. PubMed ID: 2318594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of chromatic, spatial, and temporal sensitivity in optic nerve disease.
    Grigsby SS; Vingrys AJ; Benes SC; King-Smith PE
    Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3252-62. PubMed ID: 1748555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatic and luminance losses with multiple sclerosis and optic neuritis measured using dynamic random luminance contrast noise.
    Flanagan P; Zele AJ
    Ophthalmic Physiol Opt; 2004 May; 24(3):225-33. PubMed ID: 15130171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromatic and luminance contrast sensitivities in asymptomatic carriers from a large Brazilian pedigree of 11778 Leber hereditary optic neuropathy.
    Ventura DF; Quiros P; Carelli V; Salomão SR; Gualtieri M; Oliveira AG; Costa MF; Berezovsky A; Sadun F; de Negri AM; Sadun AA
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4809-14. PubMed ID: 16303983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatio-temporal selectivity of loss of colour and luminance contrast sensitivity with multiple sclerosis and optic neuritis.
    Flanagan P; Markulev C
    Ophthalmic Physiol Opt; 2005 Jan; 25(1):57-65. PubMed ID: 15649184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Spatial contrast sensitivity in multiple sclerosis].
    Vighetto A; Grochowicki M; Cousin J
    Rev Neurol (Paris); 1990; 146(4):264-70. PubMed ID: 2359900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatic discrimination losses in multiple sclerosis patients with and without optic neuritis using the Cambridge Colour Test.
    Moura AL; Teixeira RA; Oiwa NN; Costa MF; Feitosa-Santana C; Callegaro D; Hamer RD; Ventura DF
    Vis Neurosci; 2008; 25(3):463-8. PubMed ID: 18598419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal and cortical evoked responses to chromatic contrast stimuli. Specific losses in both eyes of patients with multiple sclerosis and unilateral optic neuritis.
    Porciatti V; Sartucci F
    Brain; 1996 Jun; 119 ( Pt 3)():723-40. PubMed ID: 8673486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orientational contrast sensitivity and chromatic contrast thresholds in multiple sclerosis.
    Jackson TL; Ong GL; Ripley LG
    Am J Ophthalmol; 2004 Feb; 137(2):283-6. PubMed ID: 14962418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Spatial contrast sensitivity in the differential diagnosis of optic neuritis].
    Karlova IZ; Shamshinova AM; Belozerov AE; Loskutov IA
    Vestn Oftalmol; 1996; 112(3):21-4. PubMed ID: 8966858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective broad-band spatial frequency loss in contrast sensitivity functions. Comparison with a model based on optical transfer functions.
    Bour LJ; Apkarian P
    Invest Ophthalmol Vis Sci; 1996 Nov; 37(12):2475-84. PubMed ID: 8933764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in chromatic and achromatic contrast sensitivities following tropicamide administration.
    Lee EJ; Ong G; Rajak S; Casswell AG
    Eye (Lond); 2007 Feb; 21(2):187-90. PubMed ID: 16294202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychophysical investigations of the temporal modulation sensitivity function in amblyopia: spatiotemporal interactions.
    Manny RE; Levi DM
    Invest Ophthalmol Vis Sci; 1982 Apr; 22(4):525-34. PubMed ID: 7061221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast sensitivity loss in multiple sclerosis. Selectivity by eye, orientation, and spatial frequency measured with the evoked potential.
    Kupersmith MJ; Seiple WH; Nelson JI; Carr RE
    Invest Ophthalmol Vis Sci; 1984 Jun; 25(6):632-9. PubMed ID: 6724832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis.
    Fisher JB; Jacobs DA; Markowitz CE; Galetta SL; Volpe NJ; Nano-Schiavi ML; Baier ML; Frohman EM; Winslow H; Frohman TC; Calabresi PA; Maguire MG; Cutter GR; Balcer LJ
    Ophthalmology; 2006 Feb; 113(2):324-32. PubMed ID: 16406539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Color vision defect type and spatial vision in the optic neuritis treatment trial.
    Schneck ME; Haegerstrom-Portnoy G
    Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2278-89. PubMed ID: 9344351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonselective losses in foveal chromatic and luminance sensitivity in multiple sclerosis.
    Foster DH; Snelgar RS; Heron JR
    Invest Ophthalmol Vis Sci; 1985 Oct; 26(10):1431-41. PubMed ID: 4044171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective loss of chromatic sensitivity in demyelinating disease.
    Fallowfield L; Krauskopf J
    Invest Ophthalmol Vis Sci; 1984 Jun; 25(6):771-3. PubMed ID: 6724848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities of chromatic and luminance critical flicker frequency in multiple sclerosis.
    Mason RJ; Snelgar RS; Foster DH; Heron JR; Jones RE
    Invest Ophthalmol Vis Sci; 1982 Aug; 23(2):246-52. PubMed ID: 7096020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Images perceived after chromatic or achromatic contrast sensitivity losses.
    Luque MJ; Capilla P; de Fez MD; García-Domene MC
    Optom Vis Sci; 2010 May; 87(5):E313-22. PubMed ID: 20386355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.